European Journal of Immunology

Article	Citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)	252
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset	180
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients	108
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action	98
Human NK cells, their receptors and function	96
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments	94
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy	82
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans	67
Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction	66
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15	64
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway	62
The expanding world of tissue‐resident macrophages	60
JAK inhibitors: Ten years after	58
Treg cell therapy: How cell heterogeneity can make the difference	58
Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease	57
CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties	53
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients	51
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris	50
Complement cascade in severe forms of COVID‐19: Recent advances in therapy	47
Helios is a marker, not a driver, of human Treg stability	46
CAR T cells: Building on the CD19 paradigm	45
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development	44
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients	43
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis	41
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy	40

Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease	40
Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis	40
Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils	39
Altered increase in STAT1 expression and phosphorylation in severe COVID‐19	39
Metabolic reprograming shapes neutrophil functions in severe COVID‐19	39
Regulatory T‐cell development in the tumor microenvironment	37
Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α	36
The role of the gut microbiota and microbial metabolites in neuroinflammation	36
Anti‐heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID‐19	36
IL‐17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone‐forming cells in ankylosing spondylitis	35
A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice	34
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver	33
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis	32
Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity	32
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination	32
Molecular mechanisms of nonself nucleic acid recognition by the innate immune system	31
Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity	30
Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance	30
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver	30
An integrative genomics approach identifies KDM4 as a modulator of trained immunity	29
The role of cGAS/STING in intestinal immunity	29
IL‐33/ST2 as a potential target for tumor immunotherapy	28
Protection against allergies: Microbes, immunity, and the farming effect	28
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection	28
Antigen‐driven PD‐1+TOX+BHLHE40+ and PD‐1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis	27
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection	27
Collagen type VI is the antigen recognized by the ER‐TR7 antibody	27
Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs	26
Mechanisms of exTreg induction	26
Human dendritic cell subsets: An updated view of their ontogeny and functional specialization	26
Neuroimmune interactions in peripheral tissues	26
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects	26
RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches	25
Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID‐19	25
Identification of human cytotoxic ILC3s	25
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches	25
T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation	24
The association of Epstein‐Barr virus infection with CXCR3+ B‐cell development in multiple sclerosis: impact of immunotherapies	24
Regulation of the humoral type 2 immune response against allergens and helminths	24
Measuring single‐cell protein secretion in immunology: Technologies, advances, and applications	24
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients	23
Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects	23
Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells, and microbiota	23
Maintenance of quiescent immune memory in the bone marrow	23
CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells	22
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy	22
TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis	22
Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry	22
Autophagy regulates long‐term cross‐presentation by murine dendritic cells	22
CTRP4 acts as an anti‐inflammatory factor in macrophages and protects against endotoxic shock	22

Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis	21
Innate lymphoid cells and cancer: Role in tumor progression and inhibition	21
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis	21
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive	21
Towards gene therapy for IPEX syndrome	20
Metabolic dynamics instruct CD8+ T‐cell differentiation and functions	20
T‐cell memory in tissues	20
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2	20
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	20
ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro	19
ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination	19
Cross talk between human regulatory T cells and antigen‐presenting cells: Lessons for clinical applications	19
Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis	19
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments	19
Specificity of mouse and human Fcgamma receptors and their polymorphic variants for IgG subclasses of different species	18
Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions	18
Heterogeneity of germinal center B cells: New insights from single‐cell studies	18
GSDMD‐mediated NETosis promotes the development of acute respiratory distress syndrome	18
Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer	18
The thioredoxin system: Balancing redox responses in immune cells and tumors	18
Human liver‐derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR‐independent activation	18
SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10	18
Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis	18
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model	18
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming	17
Emerging imaging and liquid biomarkers in multiple sclerosis	17
The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19	17
De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cells	17
Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis	17
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities	16
Interleukin‐21 in autoimmune and inflammatory skin diseases	16
IgE in the pathophysiology and therapy of food allergy	16
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods	16
Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL‐2 expression to ameliorate DSS‐induced colitis	16
Withdrawn	16
4‐1BB costimulation promotes bystander activation of human CD8 T cells	16
Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes	16
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein	16
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes‐1 negatively regulates human neutrophils	16
Insights into coronavirus immunity taught by the murine coronavirus	16
Towards prevention of autoimmune diseases: The example of rheumatoid arthritis	16
AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection	15
Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children	15
Four challenges to CAR T cells breaking the glass ceiling	15
CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts	15
Regulatory T cells as a therapeutic approach for inflammatory bowel disease	15
miR‐148a controls metabolic programming and survival of mature CD19‐negative plasma cells in mice	15
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer	14
Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility	14
T helper cell subsets: diversification of the field	14
Differential effects of estradiol and progesterone on human T cell activation in vitro	14
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies	14
Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis	14
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders	14
Human NK cells responses are enhanced by CD56 engagement	14
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection	14
TFF3 mediates the NF‐κB/COX2 pathway to regulate PMN‐MDSCs activation and protect against necrotizing enterocolitis	13
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire	13
Hobit and Blimp‐1 regulate TRM abundance after LCMV infection by suppressing tissue exit pathways of TRMprecursors	13
Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice	13
Abortive HIV‐1 RNA induces pro‐IL‐1β maturation via protein kinase PKR and inflammasome activation in humans	13
cGAS‐STING signaling in cell death: Mechanisms of action and implications in pathologies	13
Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity	13
Loss of microRNA‐147 function alleviates synovial inflammation through ZNF148 in rheumatoid and experimental arthritis	12
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells	12
Epigenetic regulation in antiviral innate immunity	12
Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells	12
EGFR ligands synergistically increase IL‐17A‐induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3	12
Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes	12
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients	12
Macrophage plasticity as a therapeutic target in tuberculosis	12
Human CXCR5+PD‐1+ CD8 T cells in healthy individuals and patients with hematologic malignancies	12
Langerhans cells in the skin and oral mucosa: Brothers in arms?	12
Classical DC2 subsets and monocyte‐derived DC: Delineating the developmental and functional relationship	12
Splenic erythroid progenitors decrease TNF‐α production by macrophages and reduce systemic inflammation in a mouse model of T cell‐induced colitis	12
Guidelines for mouse and human DC generation	12
Human myeloid‐derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data	12
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies	11
TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction	11
Interleukin‐34 accelerates intrauterine adhesions progress related to CX3CR1+ monocytes/macrophages	11

Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity	11
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity	11
mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapy	11
Altered follicular regulatory T (Tfr)‐ and helper T (Tfh)‐cell subsets are associated with autoantibody levels in microscopic polyangiitis patients	11
Macrophage and monocyte subsets in response to ischemic stroke	11
Mast cells in type 2 skin inflammation: Maintenance and function	11
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice	11
Eomesodermin‐expressing type 1 regulatory (EOMES+Tr1)‐like T cells: Basic biology and role in immune‐mediated diseases	11
One year of Young EFIS: achievements and future directions	11
UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation	11
Structure‐guided stabilization of pathogen‐derived peptide‐HLA‐E complexes using non‐natural amino acids conserves native TCR recognition	10
TNFR2 expression is a hallmark of human memory B cells with suppressive function	10
Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single‐cell analysis	10
Plasmacytoid dendritic cells regulate host immune response to Citrobacter rodentium induced colitis in colon‐draining lymph nodes	10
Stereotyped B‐cell responses are linked to IgG constant region polymorphisms in multiple sclerosis	10
Commensal fungi and their cell‐wall β‐glucans direct differential responses in human intestinal epithelial cells	10
Monocytes mediate Salmonella Typhimurium‐induced tumor growth inhibition in a mouse melanoma model	10
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation	10
Single‐reaction multi‐antigen serological test for comprehensive evaluation of SARS‐CoV‐2 patients by flow cytometry	10
P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell death	10
A conserved pathway of transdifferentiation in murine Kupffer cells	10
Dendritic cells Trigger IFN‐γ secretion by NK cells independent of IL‐12 and IL‐18	10
Resolving trained immunity with systems biology	10
Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results	10
Single‐cell resolution of plasma cell fate programming in health and disease	10
Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis	10
COVID‐19 rapidly increases MDSCs and prolongs innate immune dysfunctions	10
Bystander activation of Bordetella pertussis‐induced nasal tissue‐resident memory CD4 T cells confers heterologous immunity to Klebsiella pneumoniae	10
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency	10
Mass cytometry analysis of blood immune cells from psoriasis patients on biological therapy	10
Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis	10
GFI1/HDAC1‐axis differentially regulates immunosuppressive CD73 in human tumor‐associated FOXP3+Th17 and inflammation‐linked Th17 cells	10
SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs	10
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity	10
IL‐3 regulates the differentiation of pathogenic Th17 cells	9
Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells	9
Antigen targeting to dendritic cells: Still a place in future immunotherapy?	9
Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro‐inflammatory environment even in presence of glioblastoma cells	9
Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay	9
Genetic dissection of a major haplotype associated with arthritis reveal FcγR2b and FcγR3 to act additively	9
ILC1: Development, maturation, and transcriptional regulation	9
Peptidylprolyl isomerase C (Ppic) regulates invariant Natural Killer T cell (iNKT) differentiation in mice	9
Dendritic cell functions in vivo: A user's guide to current and next‐ generation mutant mouse models	9
Fibroblastic reticular cells provide a supportive niche for lymph node–resident macrophages	9
Zbtb10 transcription factor is crucial for murine cDC1 activation and cytokine secretion	9
Multiomics uncovers developing immunological lineages in human	9
Endoplasmic reticulum stress and the inflammatory response in allergic contact dermatitis	9
Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice	9
CRISPR/Cas9 editing in conditionally immortalized HoxB8 cells for studying gene regulation in mouse dendritic cells	9
Identification of the Fc‐alpha/mu receptor in Xenopus provides insight into the emergence of the poly‐Ig receptor (pIgR) and mucosal Ig transport	9
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients	9
Regulatory T cells and transplantation tolerance: Emerging from the darkness?	9
Acquisition of human plasminogen facilitates complement evasion by the malaria parasite Plasmodium falciparum	9
T‐cell subsets in allergy and tolerance induction	9
9‐cis Retinoic acid and 1.25‐dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells	9
CD11c identifies microbiota and EGR2‐dependent MHCII+ serous cavity macrophages with sexually dimorphic fate in mice	9
SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination	9
Discriminating promiscuous from target‐specific autoantibodies in COVID‐19	9
Nitrosonisoldipine is a selective inhibitor of inflammatory caspases and protects against pyroptosis and related septic shock	9
Identification of the predominant human NK cell effector subset mediating ADCC against HIV‐infected targets coated with BNAbs or plasma from PLWH	9
Systemic lupus erythematosus patients contain B‐cell receptor repertoires sensitive to immunosuppressive drugs	9
Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases	9
Drosophila Relish‐mediated miR‐317 expression facilitates immune homeostasis restoration via inhibiting PGRP‐LC	9
Musculin is highly enriched in Th17 and IL‐22‐producing ILC3s and restrains pro‐inflammatory cytokines in murine colitis	9
Complement, complosome, and complotype: A perspective	8
Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte protein	8
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination	8
A few good reasons to use nanobodies for cancer treatment	8
Intestinal CD8+ tissue‐resident memory T cells: From generation to function	8
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function	8
Guidelines for DC preparation and flow cytometry analysis of mouse nonlymphoid tissues	8
Cytosolic d‐type CpG‐oligonucleotides induce a type I interferon response by activating the cGAS‐STING signaling pathway	8
CD28 is expressed by macrophages with anti‐inflammatory potential and limits their T‐cell activating capacity	8
IL‐13 determines specific IgE responses and SARS‐CoV‐2 immunity after mild COVID‐19 and novel mRNA vaccination	8
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy	8
Termination of CD40L co‐stimulation promotes human B cell differentiation into antibody‐secreting cells	8
Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment	8
Tumor cell‐intrinsic RIG‐I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice	8
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas	8
c‐Rel employs multiple mechanisms to promote the thymic development and peripheral function of regulatory T cells in mice	8
Advances in experimental models of rheumatoid arthritis	8
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity	8
Eosinophils interact with thymocytes and proliferate in the human thymus	7
Flow cytometry‐based high‐throughput RNAi screening for miRNAs regulating MHC class II HLA‐DR surface expression	7
Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?	7
Isolation and expansion of thymus‐derived regulatory T cells for use in pediatric heart transplant patients	7
Assessing anti‐SARS‐CoV‐2 cellular immunity in 571 vaccines by using an IFN‐γ release assay	7
Ubiquitination network in the type I IFN‐induced antiviral signaling pathway	7
Cryptococcus gattii evades CD11b‐mediated fungal recognition by coating itself with capsular polysaccharides	7
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome	7
Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice	7
Diet, commensal microbiota‐derived extracellular vesicles, and host immunity	7
SLAMF7 selectively favors degranulation to promote cytotoxicity in human NK cells	7
Myeloid‐derived suppressor cells in the therapy of autoimmune diseases	7
Z‐nucleic acids: Uncovering the functions from past to present	7